表紙
市場調査レポート

マイクロ流体 (マイクロフルイディクス) の世界市場予測 2020年:ポリマーマイクロ流体・ガラスマイクロ流体・シリコンマイクロ流体

Microfluidics Market by Material (Polymer, Glass, Silicon) Application (Pharmaceutical (Genomics, Proteomics, Capillary Electrophoresis) Diagnostic (POC, Clinical, Environmental, Industrial) Drug Delivery (Inhaler, Micropump)) - Global Forecast to 2020

発行 MarketsandMarkets 商品コード 292250
出版日 ページ情報 英文 192 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
マイクロ流体 (マイクロフルイディクス) の世界市場予測 2020年:ポリマーマイクロ流体・ガラスマイクロ流体・シリコンマイクロ流体 Microfluidics Market by Material (Polymer, Glass, Silicon) Application (Pharmaceutical (Genomics, Proteomics, Capillary Electrophoresis) Diagnostic (POC, Clinical, Environmental, Industrial) Drug Delivery (Inhaler, Micropump)) - Global Forecast to 2020
出版日: 2015年06月22日 ページ情報: 英文 192 Pages
概要

世界のマイクロ流体 (マイクロフルイディクス) 市場は2015年から2020年の予測期間中、約19%のCAGRで大きく成長すると予測されています。同市場は主に高齢者人口の増加、アジアの医療市場の成長、および政府・企業によるR&D資金の急増によって促進されています。しかし、新興市場における適切な医療・研究インフラの欠如、臨床ラボにおける高度な技能を持つ専門家の不足、および高額な統合型装置・マイクロ流体チップは同市場の成長をある程度抑制しています。

当レポートでは、世界のマイクロ流体市場について調査し、市場全体の概要と材料別、業界別、用途別の動向、地域別動向などをまとめ、参入企業のプロファイルとともに、取り上げております。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • マイクロ流体市場の概要
  • アジア太平洋地域のマイクロ流体市場:材料別
  • マイクロ流体市場:地域の成長機会
  • マイクロ流体市場:地域ミックス
  • マイクロ流体市場:先進国 vs. 新興国

第5章 市場概要

  • イントロダクション
  • 市場区分
  • 主な市場ダイナミクス

第6章 産業考察

  • イントロダクション
  • バリューチェーン分析
  • 産業動向

第7章 マイクロ流体市場:材料別

  • イントロダクション
  • ポリマーマイクロ流体
  • ガラスマイクロ流体
  • シリコンマイクロ流体
  • その他の材料マイクロ流体

第8章 世界のマイクロ流体市場:用途別

  • イントロダクション
  • 体外診断薬
    • ポイントオブ検査
    • 臨床診断
    • 農業食品検査
    • 工業用検査
    • 環境検査
  • 医薬品研究
    • ラボ分析
    • マイクロディスペンサー
    • マイクロリアクション
  • ドラッグデリバリー
    • 吸入器
    • マイクロポンプ
    • マイクロニードル

第9章 世界のマイクロ流体市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他 (ROW)

第10章 競合環境

  • 概要
  • 競合状況・動向

第11章 企業プロファイル

  • イントロダクション
  • THERMO FISHER SCIENTIFIC, INC.
  • BECTON, DICKINSON AND COMPANY
  • BIO-RAD LABORATORIES, INC.
  • PERKINELMER, INC.
  • AGILENT TECHNOLOGIES, INC.
  • DANAHER CORPORATION
  • CEPHEID INC.
  • FLUIDIGM CORPORATION
  • ROCHE DIAGNOSTICS LTD.
  • ILLUMINA, INC.
    • 事業概要
    • 提供製品
    • 近年の発展動向
    • MNMの見解、など

第12章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: BT 3517

Over the past five years, the microfluidics market has witnessed tremendous growth primarily due to rising demand for point-of-care (POC) testing, increasing use of miniaturized microfluidic chips to achieve faster testing and improved portability, and increased prevalence of age-related and lifestyle diseases and disorders.

The global microfluidics market is expected to grow at a significant CAGR of around 19% during the forecast period (2015 to 2020). The market is mainly driven by the rising geriatric population, growing Asian healthcare market, and upsurge in government and corporate funding for R&D. However, lack of adequate healthcare and research infrastructure in emerging markets, dearth of skilled professionals in clinical laboratories, and high prices of integrated instruments and microfluidics chips are hampering the growth of this market to a certain extent.

In this report, the global microfluidics market is segmented on the basis of materials and applications. On the basis of applications, the microfluidics market is divided into pharmaceutical research, in vitro diagnostics, and drug delivery. The pharmaceutical research segment is further divided into lab analytics (cell-based assays, proteomic analysis, genomic analysis, and capillary electrophoresis), dispensing, and microreaction. The in vitro diagnostics segment is categorized into clinical diagnostics, point-of-care testing, environmental testing, industrial testing, and agro food testing. The drug delivery segment is subsegmented into inhalers, microneedles, and micropumps. On the basis of materials, the microfluidics market is divided into polymer-based microfluidics, glass-based microfluidics, silicon-based microfluidics, and other material-based microfluidics. In addition, country-wise segmentation of each region (North America, Europe, Asia-Pacific, and the Rest of the World) is also provided in the report.

The in vitro diagnostics application segment accounted for a major share of the microfluidics market. This market is primarily driven by the rising demand for point-of-care testing, rising incidences of lifestyle disorders and diseases, growing geriatric population, and rapidly improving healthcare infrastructure in Asian countries.

In 2014, North America accounted for the largest share to the global microfluidics market, followed by Europe, Asia-Pacific, and RoW. However, Asia-Pacific is expected to be the fastest-growing region during the forecast period owing to the rapidly aging population, increased accessibility to healthcare facilities, and rising R&D and healthcare expenditure.

The global microfluidics market is highly fragmented; some of the major players in this market are Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), and PerkinElmer, Inc. (U.S.).

Reasons to Buy the Report:

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them to garner a greater market share. Firms purchasing the report could use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the microfluidics market. The report analyzes the microfluidics market by material and application across all regions
  • Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the microfluidics market
  • Market Development: Comprehensive information on the lucrative emerging markets by material, application, and region
  • Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the microfluidics market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the microfluidics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY AND PRICING
  • 1.5. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH APPROACH
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. MARKET SHARE ESTIMATION
    • 2.4.1. KEY DATA FROM SECONDARY SOURCES
    • 2.4.2. KEY DATA FROM PRIMARY SOURCES
    • 2.4.3. KEY INDUSTRY INSIGHTS
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. MICROFLUIDICS MARKET OVERVIEW
  • 4.2. ASIA-PACIFIC MICROFLUIDICS MARKET, BY MATERIAL
  • 4.3. MICROFLUIDICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • 4.4. MICROFLUIDICS MARKET: GEOGRAPHIC MIX
  • 4.5. MICROFLUIDICS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
    • 5.2.1. BY MATERIAL
    • 5.2.2. BY APPLICATION
  • 5.3. KEY MARKET DYNAMICS
    • 5.3.1. MARKET DRIVERS
      • 5.3.1.1. Rising demand for point-of-care (POC) testing
      • 5.3.1.2. Faster returns on investment
      • 5.3.1.3. Faster testing and improved portability through microfluidic chip miniaturization
    • 5.3.2. MARKET RESTRAINTS
      • 5.3.2.1. Incorporation of microfluidics technology into existing workflows
      • 5.3.2.2. Complex and time-consuming regulatory approval process
    • 5.3.3. MARKET OPPORTUNITIES
      • 5.3.3.1. Growing Asian market
      • 5.3.3.2. Expanding applications of drug delivery technologies
    • 5.3.4. MARKET CHALLENGES
      • 5.3.4.1. Lack of market visibility for microfluidics products
      • 5.3.4.2. High prices of integrated instruments and microfluidic sensors

6. INDUSTRY INSIGHTS 49

  • 6.1. INTRODUCTION
  • 6.2. VALUE CHAIN ANALYSIS
  • 6.3. INDUSTRY TRENDS
    • 6.3.1. SHIFTING TREND TOWARDS POLYMERS ADOPTION
    • 6.3.2. UNIVERSITIES ACTIVELY GENERATING MICROFLUIDIC STARTUPS AND LARGE PLAYERS ACQUIRING SMALL PLAYERS

7. MICROFLUIDICS MARKET, BY MATERIAL

  • 7.1. INTRODUCTION
  • 7.2. POLYMER-BASED MICROFLUIDICS
  • 7.3. GLASS-BASED MICROFLUIDICS
  • 7.4. SILICON-BASED MICROFLUIDICS
  • 7.5. OTHER MATERIAL-BASED MICROFLUIDICS

8. GLOBAL MICROFLUIDICS MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. IN VITRO DIAGNOSTICS
    • 8.2.1. POINT-OF-CARE TESTING
    • 8.2.2. CLINICAL DIAGNOSTICS
    • 8.2.3. AGRO FOOD TESTING
    • 8.2.4. INDUSTRIAL TESTING
    • 8.2.5. ENVIRONMENTAL TESTING
  • 8.3. PHARMACEUTICAL RESEARCH
    • 8.3.1. LAB ANALYTICS
      • 8.3.1.1. Proteomic analysis
      • 8.3.1.2. Genomics analysis
      • 8.3.1.3. Cell-based assays
      • 8.3.1.4. Capillary electrophoresis
    • 8.3.2. MICRODISPENSING
    • 8.3.3. MICROREACTION
  • 8.4. DRUG DELIVERY
    • 8.4.1. INHALERS
    • 8.4.2. MICROPUMPS
    • 8.4.3. MICRONEEDLES

9. GLOBAL MICROFLUIDICS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. FRANCE
    • 9.3.3. U.K.
    • 9.3.4. ITALY
    • 9.3.5. SPAIN
    • 9.3.6. REST OF EUROPE
  • 9.4. ASIA-PACIFIC
    • 9.4.1. JAPAN
    • 9.4.2. CHINA
    • 9.4.3. INDIA
    • 9.4.4. REST OF ASIA-PACIFIC
  • 9.5. REST OF THE WORLD (ROW)
    • 9.5.1. LATIN AMERICA
    • 9.5.2. MIDDLE EAST AND AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. COMPETITIVE SITUATIONS AND TRENDS
    • 10.2.1. NEW PRODUCT LAUNCHES
    • 10.2.2. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 10.2.3. EXPANSIONS
    • 10.2.4. MERGERS AND ACQUISITIONS

11. COMPANY PROFILES

  • 11.1. INTRODUCTION
  • 11.2. THERMO FISHER SCIENTIFIC, INC.
    • 11.2.1. BUSINESS OVERVIEW
    • 11.2.2. PRODUCT OFFERINGS
    • 11.2.3. RECENT DEVELOPMENTS
    • 11.2.4. MNM VIEW
  • 11.3. BECTON, DICKINSON AND COMPANY
    • 11.3.1. BUSINESS OVERVIEW
    • 11.3.2. PRODUCT OFFERINGS
    • 11.3.3. RECENT DEVELOPMENTS
    • 11.3.4. MNM VIEW
  • 11.4. BIO-RAD LABORATORIES, INC.
    • 11.4.1. BUSINESS OVERVIEW
    • 11.4.2. PRODUCT OFFERINGS
    • 11.4.3. RECENT DEVELOPMENTS
    • 11.4.4. MNM VIEW
  • 11.5. PERKINELMER, INC.
    • 11.5.1. BUSINESS OVERVIEW
    • 11.5.2. PRODUCT OFFERINGS
    • 11.5.3. RECENT DEVELOPMENTS
    • 11.5.4. MNM VIEW
  • 11.6. AGILENT TECHNOLOGIES, INC.
    • 11.6.1. BUSINESS OVERVIEW
    • 11.6.2. PRODUCT OFFERINGS
    • 11.6.3. RECENT DEVELOPMENTS
    • 11.6.4. MNM VIEW
  • 11.7. DANAHER CORPORATION
    • 11.7.1. BUSINESS OVERVIEW
    • 11.7.2. PRODUCT OFFERINGS
    • 11.7.3. RECENT DEVELOPMENTS
  • 11.8. CEPHEID INC.
    • 11.8.1. BUSINESS OVERVIEW
    • 11.8.2. PRODUCT OFFERINGS
    • 11.8.3. RECENT DEVELOPMENTS
  • 11.9. FLUIDIGM CORPORATION
    • 11.9.1. BUSINESS OVERVIEW
    • 11.9.2. PRODUCT OFFERINGS
    • 11.9.3. RECENT DEVELOPMENTS
  • 11.10. ROCHE DIAGNOSTICS LTD.
    • 11.10.1. BUSINESS OVERVIEW
    • 11.10.2. PRODUCT OFFERINGS
    • 11.10.3. RECENT DEVELOPMENTS
  • 11.11. ILLUMINA, INC.
    • 11.11.1. BUSINESS OVERVIEW
    • 11.11.2. PRODUCT OFFERINGS
    • 11.11.3. RECENT DEVELOPMENTS

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. ADDITIONAL DEVELOPMENTS, 2012-2015
  • 12.4. AVAILABLE CUSTOMIZATIONS
  • 12.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: RISING DEMAND FOR POINT-OF-CARE TESTING TO FUEL THE GROWTH OF THE MICROFLUIDICS MARKET
  • TABLE 2: CHALLENGES IN INCORPORATING MICROFLUIDICS TECHNOLOGY INTO EXISTING WORKFLOWS HINDERING THE GROWTH OF MICROFLUIDICS MARKET
  • TABLE 3: GROWING ASIAN MARKET TO EXPECTED TO PROVIDE SIGNIFICANT GROWTH OPPORTUNITY FOR THE GROWTH OF MICROFLUIDICS MARKET
  • TABLE 4: LACK OF MARKET VISIBILITY FOR MICROFLUIDICS PRODUCTS PRESENT A MAJOR CHALLENGE FOR THE GROWTH OF MICROFLUIDICS MARKET
  • TABLE 5: LIST OF UNIVERSITY STARTUPS IN THE MICROFLUIDICS MARKET
  • TABLE 6: LIST OF ACQUISITIONS IN THE MICROFLUIDICS MARKET
  • TABLE 7: GLOBAL MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 8: GLOBAL MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 9: GLOBAL POLYMER-BASED MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 10: GLOBAL GLASS-BASED MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 11: GLOBAL SILICON-BASED MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 12: GLOBAL OTHER MATERIAL-BASED MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 13: GLOBAL MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 14: GLOBAL MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 15: GLOBAL MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 16: GLOBAL MICROFLUIDICS MARKET SIZE FOR POINT-OF-CARE TESTING APPLICATION, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 17: GLOBAL MICROFLUIDICS MARKET SIZE FOR CLINICAL DIAGNOSTICS APPLICATION, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 18: GLOBAL MICROFLUIDICS MARKET SIZE FOR AGRO FOOD TESTING APPLICATION, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 19: GLOBAL MICROFLUIDICS MARKET SIZE FOR INDUSTRIAL TESTING APPLICATION, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 20: GLOBAL MICROFLUIDICS MARKET SIZE FOR ENVIRONMENTAL TESTING APPLICATION, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 21: GLOBAL MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 22: GLOBAL MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 23: GLOBAL MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 24: GLOBAL MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 25: GLOBAL MICROFLUIDICS MARKET SIZE FOR PROTEOMIC ANALYSIS APPLICATION, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 26: GLOBAL MICROFLUIDICS MARKET SIZE FOR GENOMIC ANALYSIS APPLICATION, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 27: GLOBAL MICROFLUIDICS MARKET SIZE FOR CELL-BASED ASSAYS APPLICATION, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 28: GLOBAL MICROFLUIDICS MARKET SIZE FOR CAPILLARY ELECTROPHORESIS APPLICATION, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 29: GLOBAL MICROFLUIDICS MARKET SIZE FOR MICRODISPENSING APPLICATION, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 30: GLOBAL MICROFLUIDIC MARKET SIZE FOR MICROREACTION APPLICATION, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 31: GLOBAL MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 32: GLOBAL MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 33: GLOBAL MICROFLUIDICS INHALERS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 34: GLOBAL MICROPUMPS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 35: GLOBAL MICRONEEDLES MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 36: GLOBAL MICROFLUDICS MARKET SIZE, BY REGION
  • TABLE 37: NORTH AMERICA: MICROFLUIDICS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION)
  • TABLE 38: NORTH AMERICA: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 39: NORTH AMERICA: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 40: NORTH AMERICA: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 41: NORTH AMERICA: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 42: NORTH AMERICA: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 43: NORTH AMERICA: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 44: U.S.: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 45: U.S.: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 46: U.S.: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 47: U.S.: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 48: U.S.: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 49: U.S.: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 50: CANADA: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 51: CANADA: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 52: CANADA: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 53: CANADA: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 54: CANADA: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 55: CANADA: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 56: EUROPE: MICROFLUIDICS MARKET SIZE, BY COUNTRY/REGION, 2013-2020 ($MILLION)
  • TABLE 57: EUROPE: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 58: EUROPE: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 59: EUROPE: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 60: EUROPE: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 61: EUROPE: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 62: EUROPE: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 63: GERMANY: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 64: GERMANY: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 65: GERMANY: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 66: GERMANY: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 67: GERMANY: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 68: GERMANY: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 69: FRANCE: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 70: FRANCE: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 71: FRANCE: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 72: FRANCE: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 73: FRANCE: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 74: FRANCE: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 75: U.K.: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 76: U.K.: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 77: U.K.: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 78: U.K.: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 79: U.K.: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 80: U.K.: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 81: ITALY: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 82: ITALY: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 83: ITALY: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 84: ITALY: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 85: ITALY: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 86: ITALY: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 87: SPAIN: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 88: SPAIN: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 89: SPAIN: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 90: SPAIN: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 91: SPAIN: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 92: SPAIN: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 93: ROE: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 94: ROE: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 95: ROE: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 96: ROE: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 97: ROE: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 98: ROE: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 99: APAC: MICROFLUIDICS MARKET SIZE, BY COUNTRY/REGION, 2013-2020 ($MILLION)
  • TABLE 100: APAC: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 101: APAC: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 102: APAC: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 103: APAC: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 104: APAC: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 105: APAC: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 106: JAPAN: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 107: JAPAN: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 108: JAPAN: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 109: JAPAN: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 110: JAPAN: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 111: JAPAN: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 112: CHINA: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 113: CHINA: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 114: CHINA: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 115: CHINA: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 116: CHINA: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 117: CHINA: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 118: INDIA: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 119: INDIA: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 120: INDIA: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 121: INDIA: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 122: INDIA: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 123: INDIA: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 124: ROAPAC: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 125: ROAPAC: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 126: ROAPAC: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 127: ROAPAC: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 128: ROAPAC: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 129: ROAPAC: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 130: ROW: MICROFLUIDICS MARKET SIZE, BY REGION, 2013-2020 ($MILLION)
  • TABLE 131: ROW: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 132: ROW: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 133: ROW: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 134: ROW: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 135: ROW: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 136: ROW: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 137: LATIN AMERICA: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 138: LATIN AMERICA: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 139: LATIN AMERICA: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 140: LATIN AMERICA: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 141: LATIN AMERICA: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 142: LATIN AMERICA: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 143: MIDDLE EAST AND AFRICA: MICROFLUIDICS MARKET SIZE, BY MATERIAL, 2013-2020 ($MILLION)
  • TABLE 144: MIDDLE EAST AND AFRICA: MICROFLUIDICS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION)
  • TABLE 145: MIDDLE EAST AND AFRICA: MICROFLUIDICS MARKET SIZE FOR IN VITRO DIAGNOSTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 146: MIDDLE EAST AND AFRICA: MICROFLUIDICS MARKET SIZE FOR PHARMACEUTICAL RESEARCH APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 147: MIDDLE EAST AND AFRICA: MICROFLUIDICS MARKET SIZE FOR LAB ANALYTICS APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 148: MIDDLE EAST AND AFRICA: MICROFLUIDICS MARKET SIZE FOR DRUG DELIVERY APPLICATION, BY TYPE, 2013-2020 ($MILLION)
  • TABLE 149: NEW PRODUCT LAUNCHES, 2014-2015
  • TABLE 150: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2014-2015
  • TABLE 151: EXPANSIONS, 2012-2014
  • TABLE 152: MERGERS AND ACQUISITIONS, 2014-2015

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: IN VITRO DIAGNOSTICS TO REGISTER MAXIMUM GROWTH DURING THE FORECAST PERIOD
  • FIGURE 7: LAB ANALYTICS IS EXPECTED TO DOMINATE THE GLOBAL MICROFLUIDICS MARKET FOR PHARMACEUTICAL RESEARCH APPLICATIONS BY 2020
  • FIGURE 8: POLYMER-BASED MICROFLUIDICS WAS THE LARGEST SEGMENT OF THE GLOBAL MICROFLUIDICS MARKET IN 2015
  • FIGURE 9: NORTH AMERICA DOMINATES THE POLYMER-BASED MICROFLUIDICS MARKET
  • FIGURE 10: GEOGRAPHIC ANALYSIS: GLOBAL MICROFLUIDICS MARKET
  • FIGURE 11: EMERGING ECONOMIES OFFER SIGNIFICANT GROWTH OPPORTUNITIES FOR THE GLOBAL MICROFLUIDICS MARKET
  • FIGURE 12: JAPAN ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA-PACIFIC MICROFLUIDICS MARKET IN 2014
  • FIGURE 13: THE U.S. COMMANDED ABOUT ONE-FOURTH OF THE GLOBAL MICROFLUIDICS MARKET IN 2014
  • FIGURE 14: NORTH AMERICA WILL DOMINATE THE MICROFLUIDICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 15: CHINA TO REGISTER HIGHEST GROWTH IN THE FORECAST PERIOD
  • FIGURE 16: MICROFLUIDICS MARKET SEGMENTATION, BY MATERIAL
  • FIGURE 17: MICROFLUIDICS MARKET SEGMENTATION, BY APPLICATION
  • FIGURE 18: MICROFLUIDICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: VALUE CHAIN ANALYSIS
  • FIGURE 20: MICROFLUIDICS MARKET PLAYERS INCREASINGLY FOCUSING ON ADOPTION OF POLYMERS
  • FIGURE 21: POLYMER-BASED MICROFLUIDICS TO REGISTER MAXIMUM GROWTH IN THE FORECAST PERIOD (2015-2020)
  • FIGURE 22: IN VITRO DIAGNOSTICS APPLICATION SEGMENT DOMINATE THE GLOBAL MICROFLUIDICS MARKET
  • FIGURE 23: ASIA-PACIFIC TO REGISTER MAXIMUM GROWTH IN THE FORECAST PERIOD
  • FIGURE 24: LAB ANALYTICS HOLD THE LARGEST SHARE IN THE GLOBAL MICROFLUIDICS MARKET FOR PHARMACEUTICAL RESEARCH APPLICATION
  • FIGURE 25: PROTEOMIC ANALYSIS SEGMENT HOLDS MAJOR SHARE OF THE MICROFLUIDICS MARKET FOR LAB ANALYTICS APPLICATION
  • FIGURE 26: ASIA-PACIFIC IS THE MOST LUCRATIVE MARKET FOR DRUG DELIVERY APPLICATIONS OF MICROFLUIDICS
  • FIGURE 27: GEOGRAPHIC SNAPSHOT (2015-2020): CHINA EXPECTED TO BE THE FASTEST GROWING COUNTRY
  • FIGURE 28: NORTH AMERICA HOLDS THE MAJOR SHARE IN THE GLOBAL MICROFLUIDICS MARKET
  • FIGURE 29: EMERGING MARKET OPPORTUNITIES IN THE DEVELOPING APAC COUNTRIES
  • FIGURE 30: NEW PRODUCT LAUNCHES WAS THE KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS IN THE LAST FOUR YEARS (2012-2015)
  • FIGURE 31: BATTLE FOR MARKET SHARE: NEW PRODUCT LAUNCHES WAS THE KEY STRATEGY
  • FIGURE 32: THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • FIGURE 33: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 34: BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 35: PERKINELMER, INC.: COMPANY SNAPSHOT
  • FIGURE 36: AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • FIGURE 37: DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 38: CEPHEID INC.: COMPANY SNAPSHOT
  • FIGURE 39: FLUIDIGM CORPORATION: COMPANY SNAPSHOT
  • FIGURE 40: ROCHE DIAGNOSTICS LTD.: COMPANY SNAPSHOT
  • FIGURE 41: ILLUMINA, INC.: COMPANY SNAPSHOT
Back to Top